EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mechanistic computational modeling of monospecific and bispecific antibodies targeting interleukin-6/8 receptors

Christina M P Ray iD, Huilin Yang iD, Jamie B Spangler iD, Feilim Mac Gabhann iD

PLOS Computational Biology · 07.06.2024 · 20 (6) · e1012157

DOI: 10.1371/journal.pcbi.1012157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Computational Biology, online erschienen am 07.06.2024. Verfasst von Christina M P Ray und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America. Hauptthemen laut MEDLINE: Antibodies, Bispecific, Receptors, Interleukin-6, Receptors, Interleukin-8. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Emerson Collective, Bisciotti Foundation Translational Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The spread of cancer from organ to organ (metastasis) is responsible for the vast majority of cancer deaths; however, most current anti-cancer drugs are designed to arrest or reverse tumor growth without directly addressing disease spread. It was recently discovered that tumor cell-secreted interleukin-6 (IL-6) and interleukin-8 (IL-8) synergize to enhance cancer metastasis in a cell-density dependent manner, and blockade of the IL-6 and IL-8 receptors (IL-6R and IL-8R) with a novel bispecific antibody, BS1, significantly reduced metastatic burden in multiple preclinical mouse models of cancer. Bispecific antibodies (BsAbs), which combine two different antigen-binding sites into one molecule, are a promising modality for drug development due to their enhanced avidity and dual targeting effects. However, while BsAbs have tremendous therapeutic potential, elucidating the mechanisms underlying their binding and inhibition will be critical for maximizing the efficacy of new BsAb treatments. Here, we describe a quantitative, computational model of the BS1 BsAb, exhibiting how modeling multivalent binding provides key insights into antibody affinity and avidity effects and can guide therapeutic design. We present detailed simulations of the monovalent and bivalent binding interactions between different antibody constructs and the IL-6 and IL-8 receptors to establish how antibody properties and system conditions impact the formation of binary (antibody-receptor) and ternary (receptor-antibody-receptor) complexes. Model results demonstrate how the balance of these complex types drives receptor inhibition, providing important and generalizable predictions for effective therapeutic design.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, BispecificReceptors, Interleukin-6Receptors, Interleukin-8HumansAnimalsComputational BiologyComputer SimulationInterleukin-6MiceInterleukin-8Neoplasms

Substanzen

Antibodies, BispecificReceptors, Interleukin-6Receptors, Interleukin-8Interleukin-6Interleukin-8

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
  • Medical-Scientist Training Program, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
  • Institute for Computational Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
  • Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.

ORCID-Profile: Christina M P Ray, Huilin Yang, Jamie B Spangler, Feilim Mac Gabhann

Förderung

  • NIGMS NIH HHS
  • Emerson Collective
  • Bisciotti Foundation Translational Fund
  • Maryland Innovation Initiative from TEDCO
  • National Science Foundation Graduate Research Fellowship Program

Zitieren

APA

Ray, C. M. P., Yang, H., Spangler, J. B., & Mac Gabhann, F. (2024). Mechanistic computational modeling of monospecific and bispecific antibodies targeting interleukin-6/8 receptors. PLOS Computational Biology, 20(6), e1012157. https://doi.org/10.1371/journal.pcbi.1012157

Vancouver

Ray CMP, Yang H, Spangler JB, Mac Gabhann F. Mechanistic computational modeling of monospecific and bispecific antibodies targeting interleukin-6/8 receptors. PLOS Computational Biology. 2024;20(6):e1012157. doi:10.1371/journal.pcbi.1012157

BibTeX
@article{Ray2024,
  author = {Ray, Christina M P and Yang, Huilin and Spangler, Jamie B and Mac Gabhann, Feilim},
  title = {Mechanistic computational modeling of monospecific and bispecific antibodies targeting interleukin-6/8 receptors},
  journal = {PLOS Computational Biology},
  year = {2024},
  volume = {20},
  number = {6},
  pages = {e1012157},
  doi = {10.1371/journal.pcbi.1012157}
}
Kostenlos starten →